Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/GlobeImmune> ?p ?o }
Showing triples 1 to 68 of
68
with 100 triples per page.
- GlobeImmune abstract "GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.The company has partnerships with Celgene (established in 2009) and the National Cancer Institute for the development of cancer vaccines, and with Gilead for the development of therapeutic vaccines for the treatment of hepatitis B.With respect to financing in the absence of revenue, the company raised US$17.5 million through a Series E Preferred Stock offering in January 2010.As of August 2015, GlobeImmune had two therapeutic vaccines in clinical trials, GI-6207 and GI-6301, for the treatment of various cancers. Completed trials have addressed two other candidates, GI-4000 (the company's lead oncology candidate as of 2010) and GI-5005. Despite there being three ongoing trials, in July 2015 the company announced it would eliminate \"most of its workforce positions\" shortly following the failure of a trial examining GI-4774.".
- GlobeImmune industry Biotechnology.
- GlobeImmune locationCity Louisville,_Colorado.
- GlobeImmune numberOfEmployees "22".
- GlobeImmune thumbnail Labeled_tarmogen_MOA.jpg?width=300.
- GlobeImmune type Public_company.
- GlobeImmune wikiPageExternalLink www.globeimmune.com.
- GlobeImmune wikiPageID "34834876".
- GlobeImmune wikiPageLength "4272".
- GlobeImmune wikiPageOutDegree "26".
- GlobeImmune wikiPageRevisionID "684635900".
- GlobeImmune wikiPageWikiLink Antigen.
- GlobeImmune wikiPageWikiLink Biopharmaceutical.
- GlobeImmune wikiPageWikiLink Biotechnology.
- GlobeImmune wikiPageWikiLink Cancer.
- GlobeImmune wikiPageWikiLink Cancer_vaccine.
- GlobeImmune wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- GlobeImmune wikiPageWikiLink Category:Companies_listed_on_NASDAQ.
- GlobeImmune wikiPageWikiLink Celgene.
- GlobeImmune wikiPageWikiLink File:GlobeImmune_logo.png.
- GlobeImmune wikiPageWikiLink File:Labeled_tarmogen_MOA.jpg.
- GlobeImmune wikiPageWikiLink Genetic_engineering.
- GlobeImmune wikiPageWikiLink Gilead.
- GlobeImmune wikiPageWikiLink Hepatitis_B.
- GlobeImmune wikiPageWikiLink Immunotherapy.
- GlobeImmune wikiPageWikiLink Infection.
- GlobeImmune wikiPageWikiLink Louisville,_Colorado.
- GlobeImmune wikiPageWikiLink National_Cancer_Institute.
- GlobeImmune wikiPageWikiLink Preferred_stock.
- GlobeImmune wikiPageWikiLink Public_company.
- GlobeImmune wikiPageWikiLink T_cell.
- GlobeImmune wikiPageWikiLink Vaccine.
- GlobeImmune wikiPageWikiLink Yeast.
- GlobeImmune wikiPageWikiLinkText "GlobeImmune".
- GlobeImmune homepage www.globeimmune.com.
- GlobeImmune industry Biotechnology.
- GlobeImmune locationCity Louisville,_Colorado.
- GlobeImmune locationCountry "United States".
- GlobeImmune logo File:GlobeImmune_logo.png.
- GlobeImmune name "GlobeImmune, Inc.".
- GlobeImmune numEmployees "22".
- GlobeImmune type Public_company.
- GlobeImmune wikiPageUsesTemplate Template:As_of.
- GlobeImmune wikiPageUsesTemplate Template:Currency.
- GlobeImmune wikiPageUsesTemplate Template:Infobox_company.
- GlobeImmune wikiPageUsesTemplate Template:NASDAQ.
- GlobeImmune wikiPageUsesTemplate Template:Reflist.
- GlobeImmune subject Category:Biotechnology_companies_of_the_United_States.
- GlobeImmune subject Category:Companies_listed_on_NASDAQ.
- GlobeImmune type Agent.
- GlobeImmune type Company.
- GlobeImmune type Organisation.
- GlobeImmune type Company.
- GlobeImmune type Organization.
- GlobeImmune type Agent.
- GlobeImmune type SocialPerson.
- GlobeImmune type Thing.
- GlobeImmune type Q43229.
- GlobeImmune comment "GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens.".
- GlobeImmune label "GlobeImmune".
- GlobeImmune sameAs Q5570954.
- GlobeImmune sameAs m.0j46jsw.
- GlobeImmune sameAs Q5570954.
- GlobeImmune wasDerivedFrom GlobeImmune?oldid=684635900.
- GlobeImmune depiction Labeled_tarmogen_MOA.jpg.
- GlobeImmune homepage www.globeimmune.com.
- GlobeImmune isPrimaryTopicOf GlobeImmune.
- GlobeImmune name "GlobeImmune, Inc.".